data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Guardant Health
(NASDAQ:GH)
$43.66
3.32[8.23%]
At close: Jul 1
$43.66
00
After Hours: 4:30PM EDT
Day High/Low40.37 - 43.76
52 Week High/Low27.65 - 133.82
Open / Close40.39 / 43.66
Float / Outstanding75.3M / 101.9M
Vol / Avg.833.6K / 1.5M
Mkt Cap4.4B
P/E-
50d Avg. Price42.93
Div / Yield-
Payout Ratio-
EPS-1.21
Total Float75.3M

Guardant Health (NASDAQ:GH), Quotes and News Summary

Guardant Health (NASDAQ: GH)

Day High/Low40.37 - 43.76
52 Week High/Low27.65 - 133.82
Open / Close40.39 / 43.66
Float / Outstanding75.3M / 101.9M
Vol / Avg.833.6K / 1.5M
Mkt Cap4.4B
P/E-
50d Avg. Price42.93
Div / Yield-
Payout Ratio-
EPS-1.21
Total Float75.3M
Benzinga - Jun 16, 2022, 3:42PM
Benzinga - Jun 3, 2022, 5:04AM
Benzinga - May 9, 2022, 8:32AM
Benzinga - May 6, 2022, 11:58AM
Benzinga - May 6, 2022, 9:58AM
Benzinga - May 6, 2022, 7:42AM
Benzinga - May 5, 2022, 6:23PM
Benzinga - May 3, 2022, 2:46PM
Benzinga - May 2, 2022, 8:07AM
Benzinga - Apr 11, 2022, 3:37PM
Benzinga - Apr 4, 2022, 8:14AM
Benzinga - Mar 17, 2022, 8:10AM
Benzinga - Mar 14, 2022, 4:35PM
Benzinga - Mar 9, 2022, 8:10AM
Benzinga - Mar 8, 2022, 8:18AM
Benzinga - Feb 24, 2022, 9:28AM
Benzinga - Feb 24, 2022, 8:38AM
Benzinga - Feb 24, 2022, 8:16AM
load more
Sector: Health Care.Industry: Health Care Providers & Services
Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. The company offers Guardant 360, a blood-based (liquid biopsy) test for treatment selection in advanced stage cancer, and Guardant Omni, a broader gene panel for immuno-oncology research. The company's pipeline includes Guardant Reveal (formerly Lunar-1), for cancer recurrence detection in survivors, and Lunar-2, a liquid biopsy for early detection of cancer in higher-risk individuals, with an initial focus on colorectal cancer. Additionally, Guardant offers research development services. The United States accounts for 90% of total revenue, and other markets the remaining 10%.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-1.210-0.910 0.3000
REV95.700M96.099M399.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Guardant Health Questions & Answers

Q
How do I buy Guardant Health (GH) stock?
A

You can purchase shares of Guardant Health (NASDAQ: GH) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Guardant Health's (GH) competitors?
Q
What is the target price for Guardant Health (GH) stock?
A

The latest price target for Guardant Health (NASDAQ: GH) was reported by Piper Sandler on Friday, June 3, 2022. The analyst firm set a price target for 65.00 expecting GH to rise to within 12 months (a possible 48.88% upside). 9 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Guardant Health (GH)?
A

The stock price for Guardant Health (NASDAQ: GH) is $43.66 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Guardant Health (GH) pay a dividend?
A

There are no upcoming dividends for Guardant Health.

Q
When is Guardant Health (NASDAQ:GH) reporting earnings?
A

Guardant Health’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Guardant Health (GH) going to split?
A

There is no upcoming split for Guardant Health.

Q
What sector and industry does Guardant Health (GH) operate in?
A

Guardant Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.